ABSTRACT
The prevalence of pulmonary embolism (PE) among COVID-19 infections is significantly high. However, in resource-limited settings, appropriate computed tomography (CT) imaging is not possible for all COVID-19 patients. Very sick patients suspected of a PE may not be fit to be shifted to the CT room. Hence, it is likely that PE is underdiagnosed in Indian COVID-19 patients. Coexisting PE should be considered in all patients with influenza-like illnesses who have a Type 1 respiratory failure out of proportion to the severity of COVID-19 radiology. In this case series, we discuss the different presentations of PE in patients with COVID-19.
ABSTRACT
Primary tracheal tumours are rare and less frequently observed than bronchial tumours. Primary neurogenic tumours of the trachea as schwannomas or neurilemmomas are extremely uncommon. We report a tracheal schwannoma in a female patient who presented with breathlessness and wheeze, and she was being treated for asthma. Flexible bronchoscopy revealed a large pedunculated tracheal mass and biopsy confirmed schwannoma. She was treated with laser ablation with partial reduction of the tumour. Subsequently, she was lost to follow-up, although resection of the tumour with tracheal reconstruction was planned.
Subject(s)
Adult , Female , Humans , Asthma , Diagnosis , Biopsy , Bronchoscopy , Diagnosis, Differential , Diagnostic Errors , Dyspnea , Diagnosis , Follow-Up Studies , Neurilemmoma , Diagnosis , General Surgery , Radiography, Thoracic , Plastic Surgery Procedures , Respiratory Sounds , Diagnosis , Tomography, X-Ray Computed , Trachea , Diagnostic Imaging , Pathology , General Surgery , Tracheal Neoplasms , Diagnosis , General SurgeryABSTRACT
BACKGROUND: The immune inflammatory process in patients with sarcoidosis is not only compartmentalized within the alveolar walls, but also involves the bronchial airways. Analysis of induced sputum has been used as a non-invasive tool for investigating the airways and may reflect the endobronchial and parenchymal inflammation in patients with sarcoidosis. This present study was designed to measure the soluble pro-inflammatory cytokine levels interleukin-1 (IL-1), interleukin-6 (IL-6), tumuor necrosis factor-alpha (TNF-alpha) and percentage of macrophages expressing these cytokines in induced sputum and bronchoalveolar lavage (BAL) fluid in patients with pulmonary sarcoidosis. METHODS: Sputum induction and BAL was carried out in 27 patients with newly diagnosed sarcoidosis. Control group consisted of six patients with a normal chest radiograph (three patients with carcinoma esophagus and three patients with doubtful history of hemoptysis). Induced sputum was also obtained from 10 non-smoking, non-atopic healthy controls. RESULTS: Percentage of macrophages expressing pro-inflammatory cytokines and soluble cytokine levels in induced sputum were higher in patients with sarcoidosis compared to both groups of controls. There was good correlation between IL-6 and TNF-alpha levels (r = 0.49, 0.58 p < 0.05) and percentage of macrophages expressing all three cytokines (r = 0.56-0.71, p < 0.01) between induced sputum and BAL fluid. Mild positive correlation between cytokine levels in sputum and age was also noted (r = 0.33-0.38, p < 0.05). CONCLUSIONS: Induced sputum may reflect changes in cytokine milieu in BAL in sarcoidosis.